Radiology and Oncology's Cover Image

Radiology and Oncology

The Journal of Association of Radiology and Oncology
Uneingeschränkter Zugang
2.2
Impact Factor
3.7
CiteScore
Uneingeschränkter Zugang | 06. Aug. 2025
Laser speckle contrast imaging of perfusion in oncological clinical applications: a literature review
, ,  und   
Uneingeschränkter Zugang | 06. Aug. 2025
Comparison of MR cytometry methods in predicting immunohistochemical factor status and molecular subtypes of breast cancer
, , , , , , , , ,  und   
Uneingeschränkter Zugang | 06. Aug. 2025
Identification of hub genes predicting sensitivity to neoadjuvant chemoradiation in locally advanced rectal cancer
, , ,  und   

Uneingeschränkter Zugang | 18. Juli 2025
The influence of catheter type, the number of sutures and patients’ age on percutaneous nephrostomy displacement
,  und   
Uneingeschränkter Zugang | 18. Juli 2025
Cuproptosis-related gene CEP55 as a biomarker of pancreatic adenocarcinoma via multi-omics techniques and experimental validation
, , , ,  und   
Uneingeschränkter Zugang | 08. Juli 2025
Value of ultrasound assessment of sarcopenia in patients with diffuse large B-cell lymphoma: a prospective study
, , ,  und   
ZEITSCHRIFTENINFORMATIONEN
COVER HERUNTERLADEN

Please submit your manuscripts to Radiology and Oncology via editorial system on www.radioloncol.com

Open Access Policy

This journal provides immediate open access to its content under the Creative Commons CC BY 4.0 license. Authors who publish with this journal retain all copyrights and agree to the terms of the above-mentioned CC license.

Since Issue 4, 2022, the journal has changed its license to the Creative Commons Attribution 4.0 International License.

Open Access License

Article Processing Charge (APC)

To publish in Radiology and Oncology, authors are required to pay 1500 + VAT EUR Article Processing Charge. Exceptionally, waiver of payment may be negotiated with editorial office, at the time of article submission.

Peer Review

The review process is managed by the manuscript management software. In a single-blind process, at least two reviewers are selected according to their knowledge in the field/topic of the paper. If there is disagreement between the reviewers, a third is invited. However, the final decision to accept or reject resides with the Editor-in-Chief. The average time to first decision is 4 weeks and the types of decisions possible are: accept without revision, minor revision, major revision, or reject.

eISSN:
1581-3207
ISSN:
1318-2099
Sprache:
Englisch
Zeitrahmen der Veröffentlichung:
4 Hefte pro Jahr
Fachgebiete der Zeitschrift:
Medizin, Klinische Medizin, Allgemeinmedizin, Innere Medizin, Hämatologie, Onkologie, Radiologie